Yaz® Yasmin® Ocella® Birth Control

FDA Orders Warning Label Change Due To Yaz Blood Clots
In 2012, the FDA announced it was requiring a label change for drugs such as Yaz, which contain the chemical drospirenone, warning that the chemical may be associated with a higher risk for blood clots. Several studies have indicated the blood clots associated with the drug may be linked to an increased risk of stroke, deep vein thrombosis and pulmonary embolism injuries to the lungs. In 2009, The British Medical Journal published research from Denmark and the Netherlands linking the chemical drospirenone in Yaz to an increased risk of blood clots, a contributing factor for stroke. In October, 2011, the FDA released a study of more than 800,000 women taking oral contraceptives which showed that those taking drugs like Yaz had a 74% increased risk of developing blood clots.

If you have taken the birth control pill Yaz, and suffered from a heart attack, stroke or blood clot, then you may be eligible for financial compensation. To learn more, call Goldberg Attorneys at 800-600-6014.


For more extensive information, please visit:





Yaz among pills with higher risk of blood clots - WKYC Channel 3

FDA Warns ‘Yaz’ Birth Control Users Of Blood Clot Risks - CBS Minnesota Channel 4

Comments are closed.

Fear Itself Speech essay custom service click through the following www place | Advanced Trading Tools · Learn How to Trade Binære optioner handel click here now
visit their there essay genesis